223 related articles for article (PubMed ID: 2207345)
21. [Expression of cathepsin D in breast cancer and its clinical and histopathological correlations].
Ramírez-Ortega MC; Frías-Mendívil M; Delgado-Chávez R; Meneses-García A; Carrillo-Hernández JF; Ramírez-Ugalde MT; Zeichner-Gancz I
Rev Invest Clin; 1997; 49(5):361-8. PubMed ID: 9527695
[TBL] [Abstract][Full Text] [Related]
22. Cathepsin D and breast cancer.
Westley BR; May FE
Eur J Cancer; 1996 Jan; 32A(1):15-24. PubMed ID: 8695224
[No Abstract] [Full Text] [Related]
23. Estrogen-induced lysosomal proteases secreted by breast cancer cells: a role in carcinogenesis?
Rochefort H; Capony F; Garcia M; Cavaillès V; Freiss G; Chambon M; Morisset M; Vignon F
J Cell Biochem; 1987 Sep; 35(1):17-29. PubMed ID: 3312245
[TBL] [Abstract][Full Text] [Related]
24. Matrix-degrading proteases in hormone-dependent breast cancer.
Dickson RB; Shi YE; Johnson MD
Breast Cancer Res Treat; 1994; 31(2-3):167-73. PubMed ID: 7881096
[TBL] [Abstract][Full Text] [Related]
25. Fibroblasts capture cathepsin D secreted by breast cancer cells: possible role in the regulation of the invasive process.
Heylen N; Vincent LM; Devos V; Dubois V; Remacle C; Trouet A
Int J Oncol; 2002 Apr; 20(4):761-7. PubMed ID: 11894122
[TBL] [Abstract][Full Text] [Related]
26. Expression and regulation of Cyr61 in human breast cancer cell lines.
Tsai MS; Bogart DF; Li P; Mehmi I; Lupu R
Oncogene; 2002 Jan; 21(6):964-73. PubMed ID: 11840342
[TBL] [Abstract][Full Text] [Related]
27. Cathepsin D in the malignant progression of neoplastic diseases (review).
Leto G; Gebbia N; Rausa L; Tumminello FM
Anticancer Res; 1992; 12(1):235-40. PubMed ID: 1567172
[TBL] [Abstract][Full Text] [Related]
28. Down-regulation of cathepsin-D expression by antisense gene transfer inhibits tumor growth and experimental lung metastasis of human breast cancer cells.
Glondu M; Liaudet-Coopman E; Derocq D; Platet N; Rochefort H; Garcia M
Oncogene; 2002 Aug; 21(33):5127-34. PubMed ID: 12140763
[TBL] [Abstract][Full Text] [Related]
29. Synthetic antiestrogens modulate induction of pS2 and cathepsin-D messenger ribonucleic acid by growth factors and adenosine 3',5'-monophosphate in MCF7 cells.
Chalbos D; Philips A; Galtier F; Rochefort H
Endocrinology; 1993 Aug; 133(2):571-6. PubMed ID: 8344199
[TBL] [Abstract][Full Text] [Related]
30. Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer.
Thorpe SM; Rochefort H; Garcia M; Freiss G; Christensen IJ; Khalaf S; Paolucci F; Pau B; Rasmussen BB; Rose C
Cancer Res; 1989 Nov; 49(21):6008-14. PubMed ID: 2790815
[TBL] [Abstract][Full Text] [Related]
31. The estrogen-regulated 52K-cathepsin-D in breast cancer: from biology to clinical applications.
Rochefort H; Capony F; Augereau P; Cavailles V; Garcia M; Morisset M; Freiss G; Maudelonde T; Vignon F
Int J Rad Appl Instrum B; 1987; 14(4):377-84. PubMed ID: 3654255
[TBL] [Abstract][Full Text] [Related]
32. Estrogens and growth factors induce the mRNA of the 52K-pro-cathepsin-D secreted by breast cancer cells.
Cavailles V; Augereau P; Garcia M; Rochefort H
Nucleic Acids Res; 1988 Mar; 16(5):1903-19. PubMed ID: 3282224
[TBL] [Abstract][Full Text] [Related]
33. [Cathepsin D in diagnosis of neoplastic diseases].
Warwas M; Taurowska E
Postepy Hig Med Dosw; 1993; 47(4):277-88. PubMed ID: 8309853
[TBL] [Abstract][Full Text] [Related]
34. Regulation of cathepsin-D and pS2 gene expression by growth factors in MCF7 human breast cancer cells.
Cavailles V; Garcia M; Rochefort H
Mol Endocrinol; 1989 Mar; 3(3):552-8. PubMed ID: 2664475
[TBL] [Abstract][Full Text] [Related]
35. Anti-proliferative and anti-estrogenic effects of ICI 164,384 and ICI 182,780 in 4-OH-tamoxifen-resistant human breast-cancer cells.
Coopman P; Garcia M; Brünner N; Derocq D; Clarke R; Rochefort H
Int J Cancer; 1994 Jan; 56(2):295-300. PubMed ID: 8314314
[TBL] [Abstract][Full Text] [Related]
36. Chromatin structure of the regulatory regions of pS2 and cathepsin D genes in hormone-dependent and -independent breast cancer cell lines.
Giamarchi C; Solanas M; Chailleux C; Augereau P; Vignon F; Rochefort H; Richard-Foy H
Oncogene; 1999 Jan; 18(2):533-41. PubMed ID: 9927210
[TBL] [Abstract][Full Text] [Related]
37. Procathepsin D expression correlates with invasive and metastatic phenotype of MDA-MB-231 derived cell lines.
Ohri SS; Vashishta A; Vetvickova J; Fusek M; Vetvicka V
Int J Biol Macromol; 2007 Jul; 41(2):204-9. PubMed ID: 17397917
[TBL] [Abstract][Full Text] [Related]
38. Cathepsin D assay in primary breast cancer and lymph nodes: relationship with c-myc, c-erb-B-2 and int-2 oncogene amplification and node invasiveness.
Brouillet JP; Theillet C; Maudelonde T; Defrenne A; Simony-Lafontaine J; Sertour J; Pujol H; Jeanteur P; Rochefort H
Eur J Cancer; 1990 Apr; 26(4):437-41. PubMed ID: 2141510
[TBL] [Abstract][Full Text] [Related]
39. Mitogen-activated protein kinase (MAPK) regulates the expression of progelatinase B (MMP-9) in breast epithelial cells.
Reddy KB; Krueger JS; Kondapaka SB; Diglio CA
Int J Cancer; 1999 Jul; 82(2):268-73. PubMed ID: 10389762
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of cathepsin D as prognostic predictor in breast cancer.
Barbi GP; Margallo E; Margiocco M; Paganuzzi M; Marroni P; Costanzi B; Gatteschi B; Tanara G; Spina B; Nicolò G
Oncology; 1994; 51(4):329-33. PubMed ID: 8208515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]